Marco Bortolato
Marco Bortolato
Associate Professor, Dept. of Pharmacology and Toxicology, University of Utah
Verified email at utah.edu
Title
Cited by
Cited by
Year
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
7032005
Monoamine oxidase inactivation: from pathophysiology to therapeutics
M Bortolato, K Chen, JC Shih
Advanced drug delivery reviews 60 (13-14), 1527-1533, 2008
5352008
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
M Bortolato, RA Mangieri, J Fu, JH Kim, O Arguello, A Duranti, A Tontini, ...
Biological psychiatry 62 (10), 1103-1110, 2007
3512007
Anxiolytic-like properties of the anandamide transport inhibitor AM404
M Bortolato, P Campolongo, RA Mangieri, ML Scattoni, R Frau, V Trezza, ...
Neuropsychopharmacology 31 (12), 2652-2659, 2006
2392006
Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates
Z Justinova, RA Mangieri, M Bortolato, SI Chefer, AG Mukhin, JR Clapper, ...
Biological psychiatry 64 (11), 930-937, 2008
1562008
Novel monoamine oxidase A knock out mice with human-like spontaneous mutation
AL Scott, M Bortolato, K Chen, JC Shih
Neuroreport 19 (7), 739, 2008
1392008
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence
M Bortolato, JC Shih
International review of neurobiology 100, 13-42, 2011
1162011
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5, 8, 11, 14-tetraenamide]
G La Rana, R Russo, P Campolongo, M Bortolato, RA Mangieri, V Cuomo, ...
Journal of Pharmacology and Experimental Therapeutics 317 (3), 1365-1371, 2006
1092006
Monoamine oxidase A and A/B knockout mice display autistic-like features
M Bortolato, SC Godar, L Alzghoul, J Zhang, RD Darling, KL Simpson, ...
International Journal of Neuropsychopharmacology 16 (4), 869-888, 2013
1032013
The role of the serotonergic system at the interface of aggression and suicide
M Bortolato, N Pivac, DM Seler, MN Perkovic, M Pessia, G Di Giovanni
Neuroscience 236, 160-185, 2013
962013
Prenatal exposure to urban air nanoparticles in mice causes altered neuronal differentiation and depression-like responses
DA Davis, M Bortolato, SC Godar, TK Sander, N Iwata, P Pakbin, JC Shih, ...
PloS one 8 (5), e64128, 2013
912013
Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice
M Bortolato, K Chen, SC Godar, G Chen, W Wu, I Rebrin, MR Farrell, ...
Neuropsychopharmacology 36 (13), 2674-2688, 2011
902011
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives
S Tambaro, M Bortolato
Recent Patents on CNS Drug Discovery (Discontinued) 7 (1), 25-40, 2012
882012
Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders
S Paba, R Frau, S C Godar, P Devoto, F Marrosu, M Bortolato
Current pharmaceutical design 17 (2), 151-167, 2011
862011
Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats
NR Sciolino, M Bortolato, SA Eisenstein, J Fu, F Oveisi, AG Hohmann, ...
Neuroscience 168 (2), 371-386, 2010
842010
Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice
M Bortolato, SC Godar, S Davarian, K Chen, JC Shih
Neuropsychopharmacology 34 (13), 2746-2757, 2009
842009
The role of monoamine oxidase A in aggression: Current translational developments and future challenges
SC Godar, PJ Fite, KM McFarlin, M Bortolato
Progress in neuro-psychopharmacology and biological psychiatry 69, 90-100, 2016
802016
Adverse effects of 5α-reductase inhibitors: what do we know, don’t know, and need to know?
AM Traish, RC Melcangi, M Bortolato, LM Garcia-Segura, M Zitzmann
Reviews in Endocrine and Metabolic Disorders 16 (3), 177-198, 2015
772015
Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis
M Ballmaier, M Bortolato, C Rizzetti, M Zoli, GL Gessa, A Heinz, PF Spano
Neuropsychopharmacology 32 (10), 2098-2107, 2007
752007
Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders
DA Stetler, C Davis, K Leavitt, I Schriger, K Benson, S Bhakta, LC Wang, ...
Journal of psychiatric research 58, 69-75, 2014
732014
The system can't perform the operation now. Try again later.
Articles 1–20